Those who received the drug had a median 12% drop in low-density lipoproteins, the so-called bad cholesterol, while those receiving a placebo had a 3% increase.
Because higher levels of HDL are thought to help prevent build-up of arterial plaque, boosting levels of it in the bloodstream could be a good way to fight harmfully high levels of LDL.